Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation
NCT00755716Phase 3Completed
- Sponsor
- UConn Health
- Start
- Apr 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of topiramate in tobacco dependence (3 arms), sponsored by UConn Health. Primary endpoint: 4-week Continuous Quit Rate at the End of Treatment at 10 weeks. Started Apr 2006; status: completed.
02
Drugs
topiramate
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT00755716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755716.